NTMD humor from the ymb in reference to the company’s patent threats against HMOs who recommend generics in place of BiDil: >> I am today patenting a new formulation -- the two component generic pills scotch-taped together. Only charging 150% the "plain" generics price! << Surprising that NTMD is up sharply today based on a WSJ article (<a href='read_msg.asp?message_id=14034161'>#msg-14034161</a>) I would hardly describe as bullish.